Global Healthcare Policy Analysis 2012 - Regulatory, Pricing, and Reimbursement Assessment

8/1/2012

What are the major changes in healthcare policy that are affecting the pharmaceutical industry?

GlobalData's report "Global Healthcare Policy Analysis 2012 - Regulatory, Pricing, and Reimbursement Assessment" provides an in-depth look at the policy initiatives and regulations shaping pharmaceutical markets around the world. Focusing on the global regulatory landscape in 2012, the report integrates indepth research into the policies of major international markets with expert insight to reveal the opportunities and threats that the pharmaceutical industry is facing.

You can use this report for strategic planning to tackle the challenges of developed markets and discover prospects in emerging markets. The report covers major healthcare policy initiatives, regulatory changes and key drug approvals, and examines the myriad of regulatory issues that are constantly affecting pharmaceutical and biotechnology players.

Key Questions Answered

What are the major changes in healthcare policy that are taking place around the globe, and how do these changes affect the pharmaceutical industry?

What are the key regulatory initiatives or decisions that are driving change in various international health care markets?

How does Healthcare reform in the covered regions affect margins and potential growth opportunities for pharmaceutical manufacturers?

What are the potential implication of healthcare policy for payers including public and private insurers, and what effect does this have on the healthcare industry as a whole?

Back

Archives

GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved